-
Analysis on the trend of drug registration in 2017: the heat of class 1 chemicals does not decrease
Time of Update: 2017-12-08
Source: Xinhua news agency, Dec 8, 2017, medical network, what is the change of enterprise declaration strategy with the deepening implementation of drug registration reform in 2017?
-
26 domestic chemical drugs of Class 1 new drugs were accepted, Hengrui, Beida, Dongguang Pharmaceutical...
Time of Update: 2022-12-30
Declaration of chemical drugs Class 1 domestic production In November, CDE accepted a total of 54 domestic Class 1 new drugs (according to the acceptance number), all of which were IND applications, involving 26 varieties (statistics by drug + enterprise dimension), and most of the acceptance numbers have entered the corresponding sequence to queue for review; The following table shows the Class 1 new drugs newly produced in November.
-
31 domestic chemical drugs Class 1 new drugs were accepted, and a number of PD-1 declarations for new indications! Henlius, BeiGene, Roche...
Time of Update: 2022-09-14
Watch: Watch: The total number of acceptances by the Drug Review Center in August was 1290 (excluding review) In August, 31 new drugs of class 1 domestically produced drugs were accepted by CDE In Au
-
Livzon re-attacks chemical drugs and innovative drugs, anti-tumor class 1 new drugs are coming
Time of Update: 2021-12-25
Hospital hospital hospital pharmacy pharmacy pharmacy Medical insurance negotiations have gradually formed a "one-year talk" model, and the time for innovative drugs to enter medical insurance has been greatly shortened .
-
SHPL-49 injection, a new class 1 chemical drug of Shanghai Hutchison Pharmaceuticals, obtained NMPA and FDA clinical trial approval
Time of Update: 2021-11-04
The SHPL-49 injection was approved for clinical trials in China and the United States, marking the staged success of the collaborative innovation and achievement transformation of Shanghai University of Traditional Chinese Medicine and Shanghai Hutchison Pharmaceuticals .
-
Chevron Phillips Chemical Company breaks ground on world-class 1-hexene plant
Time of Update: 2021-06-08
" Chevron Phillips Chemical Company stated that the new 1-hexene plant project in Old Ocean will enjoy significant advantages in terms of infrastructure, raw material availability and operational expertise.
-
Enhua Pharmaceutical's Class 1 chemical drug NH102 hydrochloride tablets was approved for clinical use
Time of Update: 2021-04-28
On March 15th, Enhua Pharmaceuticals issued an announcement stating that it had recently received the "Drug Clinical Trial Approval Notice" for 3 specifications of NH102 Hydrochloride Tablets, a category 1 chemical drug approved and issued by NMPA, and will start clinical trials in the near future .
-
drug king firmly sit overlord, 1 class of new drugs to open up chemical drug territory
Time of Update: 2020-12-27
Recently, the fourth batch of national harvest varieties out, in the industry caused extensive discussion, this time a total of 44 varieties of 90 products into the collection, biological agents and C
-
"13th Five-Year Plan" on the occasion of China's class 1 chemical new drug progress and trend? (Top)
Time of Update: 2020-06-17
article from: Firestone Creation Research Institute , author: Sun Xiangyu, picture from "123RF" 2020 is China's "13th Five-Year Plan" year, looking back over the past five years, China's biopharm
-
What are the progress and trend of China's class 1 chemical drug when the "13th Five-Year Plan" is closed? (lower)
Time of Update: 2020-06-15
Texts Sun Xiangyu through the "13th Five-Year Plan" to close the official, China's class 1 chemical new drug progress and trend? We understand that, after the "13th Five-Year Plan" period of efforts
-
"13th Five-Year Plan" on the occasion of China's class 1 chemical new drug progress and trend? (Lower)
Time of Update: 2020-06-05
Through the "13th Five-Year Plan" official, China's class 1 chemical new drug progress and trends? We understand that, after the "13th Five-Year Plan" period of efforts, China's class 1 chemical resea
-
"13th Five-Year Plan" official, China's class 1 chemical new drug progress and trends? (Above)
Time of Update: 2020-05-28
2020 is China's "13th Five-Year Plan" official year, looking back over the past five years, China's biopharmaceutical industry has undergone great changes, the innovative properties of industrial deve
-
"13th Five-Year Plan" on the occasion of China's class 1 chemical new drug progress and trend? (Above)
Time of Update: 2020-05-28
Texts Sun Xiangyu 2020 is China's "13th Five-Year Plan" year, looking back over the past five years, China's biopharmaceutical industry has undergone great changes, the innovative properties of ind
-
2019 CDE annual drug review report: 589 chemical class 1 applications, 1045 anda, 695 ind, 130 NDA
Time of Update: 2020-01-07
According to the latest statistics of drug intelligence data, in 2019, CDE undertook 8056 new drug registration applications with acceptance number (excluding reexamination, the same below) Influenced
-
2019 CDE annual drug review report: 589 chemical class 1 applications 1045 anda
Time of Update: 2020-01-07
According to the latest statistics of drug intelligence data, in 2019, CDE undertook 8056 new drug registration applications with acceptance number (excluding reexamination, the same below) Influenced
